News - Cellvizio - Jun 30, 2023

Mauna Kea Technologies: release of the 2022 Universal Registration Document

Paris and Boston, June 30, 2023 – 5:45 p.m. CEST – Mauna Kea Technologies (Euronext: MKEA) inventor of Cellvizio®, the multidisciplinary probe and needle-based confocal laser endomicroscopy (p/nCLE) platform, announces that it has made available to the public and filed with the Autorité des marchés financiers its Universal Registration Document for the year ending December 31, 2022. 

Mauna Kea Technologies' Universal Registration Document notably includes: 

- The 2022 financial report, comprising the consolidated financial statements, the annual financial statements and the related statutory auditors' reports; 

- The management report; 

- The corporate governance report. 

The Universal Registration Document is available on the Mauna Kea Technologies website,, in the Investors / Financial Documents section, as well as on the AMF website (